Recruiting

Mobile Health Program for Post-Preeclampsia Hypertension

ClinicalTrials.gov IDNCT07599579

PhaseNA

Enrollment50

SponsorUniversity of Pittsburgh

Age18 Years

SexFEMALE

I'm interested View official listing

Conditions studied

Hypertension (HTN), Preeclampsia, Hypertensive Disorders of Pregnancy (HDP)

About this study

Strategies targeted to optimize hypertension (HTN) control for midlife women after hypertensive disorders of pregnancy (HDP) have not been studied, despite evidence of a critical need. This proposal targets the 10-20 years postpartum as a key time when women have subclinical cardiovascular (CV) sequelae of uncontrolled HTN and are primed for CV prevention interventions. Before proceeding with large-scale intervention trials of a home blood pressure monitoring (HBPM) and coaching intervention following HDP, further pilot testing is necessary. The overarching hypothesis of this proposal is that a new monitoring and treatment paradigm utilizing HBPM combined with a virtual coaching intervention would be better than standard of care for mid-life women with prior HDP who develop HTN. Women will be assigned in an unblinded manner to the intervention or standard of care control group.

Interventions

Behavioral: Coaching application — A digital application for providing education and support for home-based blood pressure monitoring.
Behavioral: Home-based blood pressure monitoring — Device for measuring blood pressure at home with blue tooth connectivity for automated collection.
Other: WebMD — Smartphone-based application for health education and/or monitoring.

Primary outcomes

Change in systolic blood pressure from baseline to 3 months (Baseline, 3 Months)

Eligibility information

Inclusion Criteria: * Women who had a history of HDP (either gestational HTN or preeclampsia) diagnosed by ACOG guidelines at the time of delivery at Magee-Womens Hospital between 2008 and 2015, thus 10 to 20 years from their index pregnancy complicated by HDP. * Evidence of current stage 2 HTN (BP ≥ 140/90 mmHg with or without treatment with antihypertensive medication). Exclusion Criteria: * Known clinical CVD (prior myocardial infarction, stroke, heart failure, or peripheral arterial disease). * Males will also be excluded from this study as it focuses on pregnancy related conditions. * Children will be excluded as the study is only recruiting people who are 10-20 years postpartum.

Study locations

UPMC Magee Womens Hospital, Pittsburgh, Pennsylvania 15213 United States

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.